Home › Medical Devices › Bioimplants, Neurostimulation
Bioimplants, Neurostimulation Market Research Reports & Consulting
A bioimplant is a surgically implanted biomaterial used to replace damaged tissue in the human body for cardiac, orthopedic, and reconstructive purposes. A neurostimulator is an implant that helps reduce the experience of pain by replacing it with a tingling sensation. This product is mainly used for the treatment of Alzheimerís, Parkinsonís disease and chronic pain. The neurostimulation market includes product categories such as spinal cord stimulator, deep brain stimulator, vagus nerve stimulator, sacral nerve stimulator, and gastric electrical stimulator. Our market research reports also analyze the new and upcoming application markets, such as the use of neurostimulation technology for the treatment of depression and chronic heart failure. see less
A bioimplant is a surgically implanted biomaterial used to replace damaged tissue in the human body for cardiac, orthopedic, and reconstructive purposes. A neurostimulator is an implant that helps reduce the experience of pain by replacing it with a tingling sensation. This product is mainly used fo ....see more
Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitues) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2021
The global biosurgery market is estimated to grow at a CAGR of 8.8% from 2016 to 2021 to reach USD 27.78 Billion by 2021. Factors such as rising number of surgeries, rising incidences of sports related injuries & spinal problems, and rising need of effective blood loss management are major factors driving the growth of this market.
|November 2016||$ 5650|
ENT Devices Market by Product (Diagnostic (Endoscope (Rigid, Flexible), Hearing Screening), Surgical (RF, Handheld (Otology & Laryngeal), Packing Material, Ear Tubes), Hearing Aids, Lasers), & End User (Hospital & Ambulatory) - Global Forecast to 2020
The global ENT devices market is expected to reach USD 14,001 Million by 2020 from USD 9,595 Million in 2015, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by the high prevalence of chronic sinusitis, rising geriatric population, favorable reimbursement scenario for ENT procedures in developed countries, rising adoption of minimally invasive ENT procedures, increasing presence of prominent players in the ENT devices market, and technological advancements. In addition the growing adoption of surgical instruments and techniques that are minimally invasive and more accurate than the conventional methods is a key market trend that will drive the ENT devices market during the forecast period. However, changes in the reimbursement policy for Tracheoesophageal Voice Prosthesis (TEP) devices in the U.S., high cost of CO2 lasers, and high cost and lack of reimbursement for hearing aids are factors that are likely to restrict the growth of this market.
|November 2015||$ 5650|
Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019
The global soft tissue repair market is estimated to grow at a CAGR of 7.5% from 2014 to 2019 to reach $14.7 billion in 2019. The increasing incidence of soft tissue injuries among the active aging population, increasing participation in sports, increasing obesity rate, and increasing healthcare expenditure & lack of substitutes for soft tissue repair surgery are the major factors driving market growth.
|March 2015||$ 5650|
Bio-Implants Market - by Type (Cardiovascular, Spine, Orthopedics, Trauma, Dental), by ROA (Surgical/Injectable), by Origin (Allo/Auto/Xenograft, Synthetic) & Materials (Ceramics, Biomaterial, Alloys, Polymers) - Global Trends &, Forecasts till 2017
Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patientís body.
|September 2012||$ 5650|
Neurostimulation Market by Product & Applications (2012-2017) (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Transcranial Magnetic, Gastric, TENS) Global Trends, Emerging Applications & Competitive Landscape
This report provides an in-depth review of the numerous significant developments in neurostimulation technology, and the markets for this technology. It also provides in detail the competitive landscape, profiles of key players and over 100 market related tables on the neurostimulation sector.
|September 2009||$ 5650|